Jan Skvarka, Ph.D.

Jan Skvarka, Ph.D.

DirectoratMonte Rosa Therapeutics· In proxies 2023–2025

Jan Skvarka, Ph.D. sits on 3 public boards.

Boards1

  • Zentalis PharmaceuticalsDirector · 1 yr on the boardIndependentAudit, Nominating and Corporate Governance (Chair)—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Monte Rosa TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role +60%
  2. Zentalis PharmaceuticalsPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  3. DEM Biopharma, Inc.Public company · 2 yr
    • Director2024 – Present · 2 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?